Healthcare provider profile · identity verified

David Barr, M.D.

Family Practice · PHILADELPHIA, PA · NPI 1902285653

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	576	189
Amlodipine Besylate	Amlodipine Besylate	557	176
Albuterol Sulfate Hfa	Albuterol Sulfate	380	122
Omeprazole	Omeprazole	260	87
Losartan Potassium	Losartan Potassium	246	88
Diclofenac Sodium	Diclofenac Sodium	234	100
Metformin Hcl	Metformin Hcl	227	70
Fluticasone Propionate	Fluticasone Propionate	194	73
Lisinopril	Lisinopril	191	65
Hydrochlorothiazide	Hydrochlorothiazide	188	56
Carvedilol	Carvedilol	174	54
Furosemide	Furosemide	164	63
Gabapentin	Gabapentin	153	56
Pantoprazole Sodium	Pantoprazole Sodium	116	47
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	110	26
Rosuvastatin Calcium	Rosuvastatin Calcium	109	38
Metoprolol Succinate	Metoprolol Succinate	106	38
Triamcinolone Acetonide	Triamcinolone Acetonide	102	59
Hydralazine Hcl	Hydralazine Hcl	99	26
Eliquis	Apixaban	96	28
Alendronate Sodium	Alendronate Sodium	93	29
Simvastatin	Simvastatin	89	23
Tamsulosin Hcl	Tamsulosin Hcl	87	28
Glipizide	Glipizide	86	27
Allopurinol	Allopurinol	83	23
Ibuprofen	Ibuprofen	82	41
Metoprolol Tartrate	Metoprolol Tartrate	81	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	80	26
Potassium Chloride	Potassium Chloride	78	24
Prednisone	Prednisone	74	50
Oxybutynin Chloride	Oxybutynin Chloride	73	27
Tizanidine Hcl	Tizanidine Hcl	68	31
Jardiance	Empagliflozin	63	13
Levothyroxine Sodium	Levothyroxine Sodium	57	20
Sertraline Hcl	Sertraline Hcl	56	19
Meclizine Hcl	Meclizine Hcl	52	27
Nifedipine Er	Nifedipine	52	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	16
Famotidine	Famotidine	50	24
Metformin Hcl Er	Metformin Hcl	49	14
Humalog Kwikpen U-100	Insulin Lispro	47	12
Chlorthalidone	Chlorthalidone	46	13
Novolog Flexpen	Insulin Aspart	46	15
Ketoconazole	Ketoconazole	45	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	44	21
Duloxetine Hcl	Duloxetine Hcl	40	14
Trulicity	Dulaglutide	39	suppressed
Azithromycin	Azithromycin	37	33
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	20
Mirtazapine	Mirtazapine	36	11
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	13
Tramadol Hcl	Tramadol Hcl	35	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	suppressed
Clopidogrel	Clopidogrel Bisulfate	31	11
Ezetimibe	Ezetimibe	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	26
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	28	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	27	suppressed
Naproxen	Naproxen	27	15
Spironolactone	Spironolactone	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	11
Donepezil Hcl	Donepezil Hcl	26	14
Finasteride	Finasteride	26	suppressed
Loperamide	Loperamide Hcl	25	13
Ammonium Lactate	Ammonium Lactate	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	22	suppressed
Midodrine Hcl	Midodrine Hcl	22	suppressed
Atenolol	Atenolol	21	suppressed
Bumetanide	Bumetanide	21	11
Colchicine	Colchicine	21	11
Januvia	Sitagliptin Phosphate	21	suppressed
Latanoprost	Latanoprost	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	16
Ozempic	Semaglutide	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	19	suppressed
Trazodone Hcl	Trazodone Hcl	19	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Topiramate	Topiramate	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Nitroglycerin	Nitroglycerin	16	12
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Levemir Flexpen	Insulin Detemir	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Valsartan	Valsartan	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Nystatin	Nystatin	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Calcium Acetate	Calcium Acetate	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Risperidone	Risperidone	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	12	suppressed
Nateglinide	Nateglinide	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error